Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic melanoma. [electronic resource]
Producer: 20190904Description: 742-745 p. digitalISSN:- 1610-0387
- Antibodies, Monoclonal, Humanized -- adverse effects
- Complement C3 -- metabolism
- Dapsone -- therapeutic use
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Hypersensitivity -- drug therapy
- Fluorescent Antibody Technique, Direct
- Follow-Up Studies
- Humans
- Lichen Planus -- chemically induced
- Male
- Melanoma -- drug therapy
- Middle Aged
- Mouth Mucosa -- drug effects
- Neoplasm Metastasis
- Neoplasm Staging
- Pemphigoid, Bullous -- chemically induced
- Skin -- drug effects
- Skin Neoplasms -- drug therapy
- Stomatitis -- chemically induced
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Letter; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.